Our pan-cancer analysis of S100A8/A9 expression using TCGA and GTEx data also revealed the significantly higher expression of S100A8/A9 in tumor regions than in adjacent normal tissues in cervical cancer. This evidence concerns the gene IGKV1D-22 and neoplasm.